Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 124.00
+0.80 (0.65%)
At close: Mar 5, 2026
Kopran Market Cap
Kopran has a market cap or net worth of 5.95 billion as of March 5, 2026. Its market cap has decreased by -27.91% in one year.
Market Cap
5.95B
Enterprise Value
7.15B
Revenue
6.20B
Ranking
n/a
PE Ratio
36.07
Stock Price
124.00
Market Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 5.95B, an increase of 940.00%. That is a compound annual growth rate of 10.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 5.95B | -17.81% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fermenta Biotech | 9.29B |
| Venus Remedies | 8.70B |
| Wanbury | 8.48B |
| Bharat Parenterals | 7.75B |
| Anuh Pharma | 7.62B |
| Fredun Pharmaceuticals | 7.24B |
| Sudarshan Pharma Industries | 6.57B |
| Kilitch Drugs (India) | 5.56B |